These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25624859)

  • 1. Effect of common single nucleotide polymorphisms in COX-1 gene on related metabolic activity in diabetic patients treated with acetylsalicylic acid.
    Postula M; Janicki PK; Rosiak M; Kaplon-Cieslicka A; Kondracka A; Trzepla E; Filipiak KJ; Kosior DA; Czlonkowski A; Opolski G
    Arch Med Sci; 2014 Dec; 10(6):1198-205. PubMed ID: 25624859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of common single-nucleotide polymorphisms in acetylsalicylic acid metabolic pathway genes on platelet reactivity in patients with diabetes.
    Postula M; Janicki PK; Rosiak M; Kaplon-Cieslicka A; Kondracka A; Trzepla E; Filipiak KJ; Kosior DA; Czlonkowski A; Opolski G
    Med Sci Monit; 2013 May; 19():394-408. PubMed ID: 23715170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic determinants of platelet reactivity during acetylsalicylic acid therapy in diabetic patients: evaluation of 27 polymorphisms within candidate genes.
    Postula M; Kaplon-Cieslicka A; Rosiak M; Kondracka A; Serafin A; Filipiak KJ; Czlonkowski A; Opolski G; Janicki PK
    J Thromb Haemost; 2011 Nov; 9(11):2291-301. PubMed ID: 21854539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclooxygenase-1 haplotype modulates platelet response to aspirin.
    Maree AO; Curtin RJ; Chubb A; Dolan C; Cox D; O'Brien J; Crean P; Shields DC; Fitzgerald DJ
    J Thromb Haemost; 2005 Oct; 3(10):2340-5. PubMed ID: 16150050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the urine and plasma determinants of thromboxane A2 metabolism in detection of aspirin effectiveness.
    Dobaczewski M; Nocun M; Zavodnik I; Ulicna O; Lapshina E; Zavodnik L; Golanski J; Kazmierczak P; Durackova Z; Kostka B; Markuszewski L; Watala C
    Blood Coagul Fibrinolysis; 2008 Jul; 19(5):421-8. PubMed ID: 18600093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New single-nucleotide polymorphisms associated with differences in platelet reactivity and their influence on survival in patients with type 2 diabetes treated with acetylsalicylic acid: an observational study.
    Milanowski L; Pordzik J; Janicki PK; Kaplon-Cieslicka A; Rosiak M; Peller M; Tyminska A; Ozieranski K; Filipiak KJ; Opolski G; Mirowska-Guzel D; Postula M
    Acta Diabetol; 2017 Apr; 54(4):343-351. PubMed ID: 27995340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of effect of common single nucleotide polymorphisms in leukotriene pathway genes on platelet reactivity in patients with diabetes.
    Rosiak M; Postula M; Kaplon-Cieslicka A; Kondracka A; Trzepla E; Zaremba M; Filipiak KJ; Kosior DA; Czlonkowski A; Opolski G; Janicki PK
    Mol Med Rep; 2013 Sep; 8(3):853-60. PubMed ID: 23828562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of very low dose and enteric-coated acetylsalicylic acid on prostacyclin and thromboxane formation and on bleeding time in healthy subjects.
    Bode-Böger SM; Böger RH; Schubert M; Frölich JC
    Eur J Clin Pharmacol; 1998; 54(9-10):707-14. PubMed ID: 9923572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thromboxane A(2) generation, in the absence of platelet COX-1 activity, in patients with and without atherothrombotic myocardial infarction.
    DeFilippis AP; Oloyede OS; Andrikopoulou E; Saenger AK; Palachuvattil JM; Fasoro YA; Guallar E; Blumenthal RS; Kickler TS; Jaffe AS; Gerstenblith G; Schulman SP; Rade JJ
    Circ J; 2013; 77(11):2786-92. PubMed ID: 23985963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective long-term inhibition of thromboxane production but not of serotonin release in patients with coronary heart disease by 30 mg/d acetylsalicylic acid dosage.
    Gajdos M; Spustová V; Sebeková K; Krivosiková Z; Dzúrik R
    Prostaglandins Leukot Essent Fatty Acids; 1998 Jul; 59(1):17-21. PubMed ID: 9758203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of plasma concentrations of salicylic acid and high on ASA platelet reactivity in type 2 diabetes patients.
    Postula M; Janicki PK; Rosiak M; Przybylkowski A; Kaplon-Cieslicka A; Grygorowicz T; Trzepla E; Filipiak KJ; Czlonkowski A; Opolski G
    Cardiol J; 2013; 20(2):170-7. PubMed ID: 23558875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiplate
    Roullet S; Labrouche S; Carrie C; Auque H; Berard X; Freyburger G
    J Thromb Haemost; 2018 Mar; 16(3):583-591. PubMed ID: 29314596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining platelet response to acetylsalicylic acid: the relation between inhibition of serum thromboxane B
    Gurbel PA; Bliden KP; Tantry US
    J Thromb Thrombolysis; 2021 Feb; 51(2):260-264. PubMed ID: 33170486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of cyclo-oxygenase-1 in high-salt diet-induced microvascular dysfunction in humans.
    Cavka A; Cosic A; Jukic I; Jelakovic B; Lombard JH; Phillips SA; Seric V; Mihaljevic I; Drenjancevic I
    J Physiol; 2015 Dec; 593(24):5313-24. PubMed ID: 26498129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No effects of atorvastatin (10 mg/d or 80 mg/d) on nitric oxide, prostacyclin, thromboxane and oxidative stress in type 2 diabetes mellitus patients of the DALI study.
    Tsikas D; Pham VV; Suchy MT; van de Ree MA; Huisman MV; Frölich JC; Princen HM;
    Pharmacol Res; 2015 Apr; 94():1-8. PubMed ID: 25662039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One milligramme of acetylsalicylic acid daily inhibits platelet thromboxane A2 production.
    Toivanen J; Ylikorkala O; Viinikka L
    Thromb Res; 1984 Sep; 35(6):681-7. PubMed ID: 6506023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New single nucleotide polymorphisms associated with differences in platelets reactivity in patients with type 2 diabetes treated with acetylsalicylic acid: genome-wide association approach and pooled DNA strategy.
    Postula M; Janicki PK; Rosiak M; Kaplon-Cieslicka A; Trzepla E; Filipiak KJ; Kosior DA; Czlonkowski A; Opolski G
    J Thromb Thrombolysis; 2013 Jul; 36(1):65-73. PubMed ID: 23054467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variants in PPARGC1B and CNTN4 are associated with thromboxane A
    McCarthy NS; Vangjeli C; Surendran P; Treumann A; Rooney C; Ho E; Sever P; Thom S; Hughes AD; Munroe PB; Howard P; Johnson T; Caulfield M; Shields DC; O'Brien E; Fitzgerald DJ; Stanton AV
    Atherosclerosis; 2018 Feb; 269():42-49. PubMed ID: 29258006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation.
    Davì G; Ciabattoni G; Consoli A; Mezzetti A; Falco A; Santarone S; Pennese E; Vitacolonna E; Bucciarelli T; Costantini F; Capani F; Patrono C
    Circulation; 1999 Jan; 99(2):224-9. PubMed ID: 9892587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. rs5911 and rs3842788 Genetic Polymorphism, Blood Stasis Syndrome, and Plasma TXB2 and hs-CRP Levels Are Associated with Aspirin Resistance in Chinese Chronic Stable Angina Patients.
    Xue M; Yang X; Yang L; Kou N; Miao Y; Wang M; Ren J; Zhao Q
    Evid Based Complement Alternat Med; 2017; 2017():9037094. PubMed ID: 28465708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.